Skip To Main Content
Maroie Barkati on Muck Rack

Maroie Barkati

As seen in: International Journal of Radiation Oncology*Biology*Physics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maroie

Contact Maroie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PSMA-PET/CT guided intensification of radiotherapy for prostate cancer (PSMAgRT): Findings of detection rate, impact on cancer management, and early toxicity from a phase 2 randomised controlled trial

|
By Guila Delouya, Daniel Taussky, Maroie Barkati
| International Journal of Radiation Oncology*Biology*Physics Verified
Purpose Prostate specific membrane antigen (PSMA) ligand positron emission tomography (PET) is increasingly integrated in prostate cancer management due to its diagnostic performance. We sought to evaluate the impact of PSMA-PET/CT-guided intensification of radiotherapy (PSMAgRT) on patient outcomes. Here, we report secondary trial endpoints including the rate of new lesion detection, impact on prostate cancer management, and treatment-related toxicities.
Open in Who Shared Issue with article?
See all 1 articles